RxDoctor Payments DataLook up a doctor →

Jennifer Snyder, NP

Family · New Carlisle, INNPI 1770573040

Payments from drug & device makers

$14,255in general payments, 2019–2025

Across 757 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Boehringer Ingelheim$908
  • Pfizer$646
  • Merck$569
  • Amgen$551
  • plus $8K from 48 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie108$1,930
Novo Nordisk69$1,211
Boehringer Ingelheim51$908
Pfizer41$646
Merck32$569
Amgen(2 entities)37$551
Axsome Therapeutics, Inc.24$529
GSK36$515
Sumitomo Pharma America, Inc.22$469
Paratek Pharmaceuticals, Inc.25$458
Corium, LLC18$433
Mylan Specialty L.p.15$405
Napo Pharmaceuticals Inc15$382
Takeda Pharmaceuticals U.S.A., Inc.18$325
Sunovion Pharmaceuticals Inc.19$324
AstraZeneca15$291
Lundbeck LLC15$282
Lilly USA, LLC12$252
Antares Pharma, Inc.14$246
Viiv Healthcare Company8$214
Johnson & Johnson(2 entities)13$207
Phathom Pharmaceuticals, Inc.5$196
Abbott10$190
Astellas Pharma US Inc5$187
Ardelyx, Inc.8$165
Otsuka America Pharmaceutical, Inc.6$158
Novartis7$157
Kowa Pharmaceuticals America, Inc.11$156
Biohaven Pharmaceutical Holding Company Ltd.7$144
Amarin Pharma, Inc.7$143
Bayer7$138
Gilead8$130
Biohaven Pharmaceuticals, Inc.5$105
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$104
Esperion Therapeutics, Inc.5$101
Exact Sciences5$98
Idorsia Pharmaceuticals US Inc5$91
Eisai Inc.5$79
Dexcom, Inc.4$78
Verity Pharmaceuticals Inc.2$73
Theratechnologies Inc.2$70
Insulet Corporation4$68
Endo Pharmaceuticals Inc.3$63
EMD Serono, Inc.2$57
Halozyme Inc3$52
Supernus Pharmaceuticals, Inc.3$49
Genentech USA, Inc.5$42
Viatris Specialty LLC2$41
Radius Health, Inc.2$38
Biogen2$36
Nabriva Therapeutics, PLC2$32
Janssen Products, LP1$31
Inspire Medical Systems, Inc.1$23
Neurocrine Biosciences, Inc.1$17

How this compares

$14,255 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana →

Medicare billing

Part B allowed, 2024
$76,564
Medicare patients
173
Services billed
10,338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in New Carlisle

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →